Children's hospital and Kantonsspital, 9000 S t . Gallen Malignant lymphoma with leukemic conversion is characterized by a rapid tumor progression and poor prognosis. In acute lymphocytic leukemia however the outlook has impmved markedly in the l a s t years. Uany children exhibit complete remission for a long time and cure is even possible. In order t o d i f f e r e n t i a t e between t h i s two diseases and t o t r e a t patients separately, we analyzed the c l i n i c a l data of 8 children, aged 2 t o 12 years, who entered the children's hospital of St. Gallen i n the l a s t year. Based on c l i n i c a l findings and with the aid of a biopsy (EM), cytochemical and immunological studies, we interpreted Ir patients a s stage IV non Hodgkin lymphoma with leukemic transformation and Ir patients a s acute lymphocytic leukemia. Of the 1( patients with malignant lymphoma, diffuse lymphoblastic, t h e new e n t i t y "convoluted type" was seen i n 2 patients. One was a 3 months old baby with probably congenital m a l i e a n t lymphoma. The distinction between acute lymphocytic leukemia and non Hodgkin lymphoma with bone mamw involvement is made on c l i n i c a l c r i t e r i a s . These c r i t e r i a s a r e discussed. In an attempt t o reduce CNS involvezect i n high r i s k childhood acute lymphocytic leukemia, 500 mg/m2 methotrsate (MTX) a s a 4-hour infusion was added t o the skull irradiation of 2400 raffi and slxth intrathecal MTX injection, followed by Leucovorin resccs a t 24 hours. MTX levels were measured by an 1~~5 NTX competetive enzfle binding technique (New England Enzyre Center, Boston). I n 8 children r i t h high r i s k acute lymphocytic leukelia very high CSF levels, 2.5~10-4 and 1.6~10-6 at 4 and 23 hours respective1 were found, a s compared rrl'.h pilrallel serum levels of 9.9~10-4 and 7.3~10-?. I n contrast, a 5 gm/mZ I.TX 6-hour infusion without intrathecal MTX failed t o achieve "tharapeuilc" levels of 10-6 a t 24 hours. Higher SF levels were observed i n CNS md marrow relapse 1.76~10-3 and 3 . 3~1 0 -~ a t 4 and 29 hours respectively. I n two cases toxicity w a s ansoci a t n d with transient Lnereased serum crsa:Lnine and correlated with toxic MTX levels. I t is concluded that t h i s additional therapy resultod i n sustained therapeutic C; F MTX levels by preventing MTX eflux from CSF, thus giving more effective brain penetration and preventing CNS leukemia.
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VITAMIN E AND ERYTROCYTE GLUTATKIONE-PEROXIDASE I N NeVlBORN
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Plasma v i t a m i n E a n d ery?rocyte C-6-PD, GR. FK a n d GSH-Px a c t i -ERYTHROCYTE ttETABOLI PI 114 PROTEIN-ENERGY F' ALHUTRITIOA AHAEIiIA. I . GLUCOSE FiETABOLISM A I D REDUCTION OF THE ACTIVATE0 OXYGEN. P. Fondu, J . Nsve, C. Heyder-Bruckner. F. V e r t o n g e n and I.M. Eandelbaum. Cemubac ;.ledical M i s s i o n t o IRS, Lwiro, Zai're, D e p a r t m e n t s of P e d i a t r i c s and o f C l i n i c a l C h e m i s t r y , and I n s t i t u t e o f Pharmacy. v i t i e s h a v e b e e n measured i n 43 newborn i n f a n t s o n e t o t w o w e e k s F r e e I t appears : 1) that there e x i s t s in PEM an erythrocyte glycolytic abnormality limiting the 2,3-DPG increase on hypoxia; 2) that the reduction of the activated oxygen i s decreased because. f i r s t l y of a GSH-Px a c t i v i t y reduction attributable t o a selenium deficiency, and secondly of decreased GSH levels. This study was designed t o investigate the e f f e c t on the c e l l u l a r imunocompe. tence of long-term intensive combination chemotherapy (ICC). In 28 patients with A.L.L. in continuous complete remission the PHA-induced lymphocyte b l a s t c e l l proliferation (PHA-CP) and the lymphotoxin productiot~ (LT PROO) by peripheral blood lymphocytes was investigated during the i n i t i a l 18 months following of 2 112 years of ICC. PHA-CP was estimated by measuring 3~-thymidine incorporation into lymphocyte DNA during a three hour pulse on day three of culture. LT PROO was estimated by measuring ( 1 ) c e l l l y s i s (51-Cr-,,=lease) and (2) of cell metabolism (DNA synthesis) i n target cell cultures exposed t o cell-free medium from PHA-stimulated leukocyte cultures. At the time when ICC was stopped one third of the patients showed impaired PHA-CP and two thirds showed impaired LT PROD. During the i n i t i a l three months following cessation of ICC the number of patients with impaired LT PROD significantly increased. After 12 months off therapy a l l patients showed a normal PHA-CP while the LT PROD was s t i l l impaired in some of them.
s e d h e m o l y s i s i n c a s e s w i t h n o r m a l v i t a m i n E a n d n o r m a l GSH-Px s u g g e s t s t h a t p o s s i b l e m o d e r a t e d e c r e a s e o f b o t h t h e s e a n t i o x i d s t i v e a g e n t must b e c o n s i d e r e d n o t h i n g more t h a t p r e d i s p o s i n g f a c t o r .
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In contrast t o healthy individuals, a considerable number of the A.L.L. patients showed a dissociation between PHA-CP and LT PROD: defective LT PROD by lymphocytes with elevated proliferative capacity. Our data suggest that upon cessation of ICC the peripheral blood of patients with A.L.L. i s repopulated by lymphocytes with a o r even elevated pro1 i f e r a t i v e capapacity but with a defective ( o r imnature) lymphokine producing capacity. This defect of the c e l l u l a r immune function in v i t r o may persist as long a 1 1/2 years a f t e r cessation of ICC. This work was supported by grants from the '"Kind-Philipp-Stiftung f u r Leukamie-Forschung" and the "Ueutsche Forschungsgemeinschaft (SF5 37, 87)". The existence of anerythrocyte membrane abnormality in PEM anaemia i s indicated by morphological examinations (increased mean red c e l l diameter. presence of target c e l l s under optical microscopy and codocytes under scanning electronic microscopy) and by the study of the red c e l l osmotic resistance. The l a s t parameter i s increased but normalizes when patients' labelled red are transfused The study of the erythmcyte lipids discloses high cholesterol and phosphatidylcholine levels. The turnover of the membrane cholesterol i s decreased on incubation with isolated patients' LDL. The incorporation Of a labelled fatty acid i n the rmnbrane is jncreased cation leak i s evident. The plasma vitamin E levels are low. An abnormality Of the i s evident. These studies show : 1). that the increase in membrane phosphatidylcholine and cholesterol levels i s due t o a qualitative lipoprotein disturbance; 2) that the main Cause of hemolysis in PEM might be a peroxidation of the erythrocyte membrane, leading t o an increased formation of lysophosphol i p i d s .
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